Edition:
India

AnGes Inc (4563.T)

4563.T on Tokyo Stock Exchange

688JPY
7:25am IST
Change (% chg)

¥0 (+0.00%)
Prev Close
¥688
Open
¥675
Day's High
¥696
Day's Low
¥670
Volume
2,081,200
Avg. Vol
2,117,159
52-wk High
¥884
52-wk Low
¥225

Chart for

About

AnGes, Inc., formerly AnGes MG, Inc., is a Japan-based company mainly engaged in the development of genetic medicines. The Company is involved in the development of hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, among others. As of... (more)
No analyst recommendations are available for .

Overall

Beta: 1.59
Market Cap(Mil.): ¥50,402.51
Shares Outstanding(Mil.): 78.63
Dividend: --
Yield (%): --

Financials

BRIEF-AnGes submits application for marketing approval for HGF gene therapy

* Says it submits application for marketing approval to Pharmaceuticals and Medical Devices Agency (PMDA) for HGF gene therapy for the treatment of critical limb ischemia (CLI)

22 Jan 2018

Earnings vs. Estimates